Synergy between deacetylase inhibitors and IL-1β in activation of the serum amyloid A2 gene promoter

DNA and Cell Biology

Volumn 24, Issue 4, 2005, Pages 209-217

  Blais, Mylène ^a   Désilets, Antoine ^a   Asselin, Claude ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BUTYRIC ACID; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; DNA; HISTONE H4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; SERUM AMYLOID A; SERUM AMYLOID A2; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; BINDING SITE; CELL STRAIN CACO 2; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; COLON CARCINOMA; CONTROLLED STUDY; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN INDUCTION;

BINDING SITES; BLOTTING, NORTHERN; BUTYRATES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CCAAT-ENHANCER-BINDING PROTEINS; COLON; DNA PRIMERS; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HISTONES; HUMANS; HYDROXAMIC ACIDS; IMMUNOPRECIPITATION; INTERLEUKIN-1; LUCIFERASES; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; PROMOTER REGIONS (GENETICS); SERUM AMYLOID A PROTEIN; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 16844385528     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2005.24.209     Document Type: Article

References (42)

1. ANDOH, A., FUJIYAMA, Y., ARAKI, K., TAKAYA, Y., SHIMADA, M., and BAMBA, T. (1999). Counter-regulatory effect of sodium butyrate on tumor necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells. Clin. Exp. Immunol. 118, 23-29.
2. ARCHER, S.Y., and HODIN, R.A. (1999). Short-chain fatty acids and thyroid hormone interact in regulating enterocyte gene transcription. Surgery 126, 293-298.
3. BEAULIEU, J.F., and QUARONI, A. (1991). Clonal analysis of sucrase-isomaltase expression in the human colon adenocarcinoma Caco-2 cells. Biochem. J. 280, 599-608.
4. CHEN, L.F., and GREENE, W.C. (2003). Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J. Mol. Med. 81, 549-557.
5. CRESS, W.D., and SETO, S. (2000). Histone deacetylases, transcriptional control, and cancer. J. Cell. Physiol. 184, 1-16.
6. D'ARGENIO, G., and MAZZACCA, G. (1999). Short-chain fatty acid in the human colon. Relation of inflammatory bowel diseases and colon cancer. Adv. Exp. Med. Biol. 472, 149-158.
7. DÉSILETS, A., GHEORGHIU, I., YU, S.J., SEIDMAN, E.G., and ASSELIN, C. (2000). Inhibition by deacetylase inhibitors of IL-1-dependent induction of haptoglobin involves CCAAT/Enhancer-binding protein isoforms in intestinal epithelial cells. Biochem. Biophys. Res. Commun. 276, 673-679.
8. DE VILLIERS, W.J., VARILAK, G.W., DE BEER, F.C., GUO, J.T., and KINDY, M.S. (2000). Increased serum amyloid A levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. Cytokine 12, 1337-1347.
9. FUKUSHIMA, K., OGAWA, H., KITAYAMA, T., YAMADA, T., NAITO, H., FUNAYAMA, Y., MATSUNO, S., and SASAKI, I. (2002). Epithelial induction of serum amyloid A in experimental mucosal inflammation. Dig. Dis. Sci. 47, 1438-1446.
10. GABAY, C., and KUSHNER, I. (1999). Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448-454.
11. HAGIHARA, K., NISHIKAWA, T., ISOBE, T., SONG, J., SUGAMATA, Y., and YOSHIZAKI, K. (2004). IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem. Biophys. Res. Commun. 314, 363-369.
12. HARDARDOTTIR, I., SIPE, J., MOSER, A.H., FIELDING, C.J., FEINGOLD, K.R., and GRUNFELD, C. (1997). LPS and cytokines regulate extra hepatic mRNA levels of apolipoproteins during the acute-phase response in Syrian hamsters. Biochim. Biophys. Acta 1344, 210-220.
13. HOUDE, M., LAPRISE, P., JEAN, D., BLAIS, M., ASSELIN, C., and RIVARD, N. (2001). Intestinal epithelial cell differentiation involves activation of p38 mitogen-activated protein kinase that regulates the homeobox transcription factor CDX2. J. Biol. Chem. 276, 21885-21894.
14. HUANG, N., KATZ, J.P., MARTIN, D.R., and WU, G.D. (1997). Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. Cytokine 9, 27-36.
15. INAN, M.S., RASOULPOUR, R.J., YIN, L., HUBBARD, A.K., ROSENBERG, D.W., and GIARDINA, C. (2000). The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology 18, 724-734.
16. LEMISCHKA, I.R., FARMER, S., RACANIELLO, V.R., and SHARP, P.A. (1981). Nucleotide sequence and evolution of a mammalian alpha-tubulin messenger RNA. J. Mol. Biol. 151, 101-120.
17. LUHRS, H., GERKE, T., BOXBERGER, F., BACKHAUS, K., MELCHER, R., SCHEPPACH, W., and MENZEL, T. (2001a). Butyrate inhibits interleukin-1-mediated nuclear factor-kappa B activation in human epithelial cells. Dig. Dis. Sci. 46, 1968-1973.
18. LUHRS, H., GERKE, T., SCHAUBER, J., DUSEL, G., MELCHER, R., SCHEPPACH, W., and MENZEL, T. (2001b). Cytokine-activated degradation of inhibitory kappaB protein alpha is inhibited by the short-chain fatty acid butyrate. Int. J. Colorectal. Dis. 16, 195-201.
19. MANDAL, M., OLSON, D.J., SHARMA, T., VADLAMUDI, R.K., and KUMAR, R. (2001). Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Gastroenterology 120, 71-78.
20. MARINKOVIC, S., and BAUMANN, H. (1990). Structure, hormonal regulation, and identification of the interleukin-6- and dexamethasone-responsive element of the rat haptoglobin gene. Mol. Cell. Biol. 10, 1573-1583.
21. OHNO, Y., LEE, J., FUSUNYAN, R.D., MACDERMOTT, R.P., and SANDERSON, I.R. (1997). Macrophage inflammatory protein-2: Chromosomal regulation in rat small intestinal epithelial cells. Proc. Natl. Acad. Sci. USA 94, 10279-10284.
22. PELLETIER, N., BOUDREAU, F., YU, S.J., ZANNONI, S., BOULANGER, V., and ASSELIN, C. (1998). Activation of haptoglobin gene expression by cAMP involves CCAAT/enhancer-binding protein isoforms in intestinal epithelial cells. FEBS Lett. 439, 275-280.
23. PERKINS, N.D., SCHMID, R.M., DUCKETT, C.S., LEUNG, K., RICE, N.R., and NABEL, G.J. (1992). Distinct combinations of NF-κB subunits determine the specificity of transcriptional activation. Proc. Natl. Acad. Sci. USA 89, 1529-1533.
24. SAMBROOK, J., and RUSSELL, D.W. (2001). Molecular Cloning: A Laboratory Manual, 3rd ed., vol. 2 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
25. SCHEPPACH, W., SOMMER, H., KIRCHNER, T., PAGANELLI, G.M., BARTRAM, P., CHRISTL, S., RICHTER, F., DUSEL, G., and KASPER, H. (1992). Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103, 51-56.
26. SCHMITZ, M.L., and BAEUERLE, P.A. (1991). The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10; 3805-3817.
27. SEGAIN, J.P., RAINGEARD DE LA BLETIERE, D., BOURREILLE, A., LERAY, V., GERVOIS, N., ROSALES, C., FERRIER, L., BONNET, C., BLOTTIERE, H.M., and GALMICHE, J.P. (2000). Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47, 397-403.
28. SOULEIMANI, A., and ASSELIN, C. (1993a). Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2. FEBS Lett. 326, 45-50.
29. SOULEIMANI, A., and ASSELIN, C. (1993b). Regulation of c-fos expression by sodium butyrate in the human colon carcinoma cell line Caco-2. Biochem. Biophys. Res. Commun. 193, 330-336.
30. STEEL, D.M., DONOGHUE, F.C., O'NEILL, R.M., UHLAR, C.M., and WHITEHEAD, A.S. (1996). Expression and regulation of constitutive and acute phase amyloid A mRNAs in hepatic and non-hepatic cell lines. Scand. J. Immunol. 44, 493-500.
31. STEIN, B., RAHMSDORF, H.J., STEFFEN, A., LITFIN, M., and HERRLICH, P. (1989). UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol. Cell. Biol. 9, 5169-5181.
32. THORN, C.F., LU, Z.Y., and WHITEHEAD, A.S. (2004). Regulation of the human acute phase serum amyloid A genes by tumor necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines. Scand. J. Immunol. 59, 152-158.
33. TONG, X., YIN, L., and GIARDINA, C. (2004). Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition. Biochem. Biophys. Res. Commun. 317, 463-471.
34. TOPPING, D.L., and CLIFTON P.M. (2001). Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 81, 1031-1064.
35. UHLAR, C.M., and WHITEHEAD, A.S. (1999). Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265, 501-523.
36. UHLAR, C.M., GREHAN, S., STEEL, D.M., STEINKASSERER, A., and WHITEHEAD, A.S. (1997). Use of the acute phase serum amyloid A2 (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators: Differential kinetics of SAA2 promoter induction by IL-1 beta and TNF-alpha compared to IL-6. J. Immunol. Methods 203, 123-130.
37. URIELI-SHOVAL, S., LINKE, R.P., and MATZNER, Y. (2000). Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol. 7, 64-69.
38. VENKATRAMAN, A., RAMAKRISHNA, B.S., SHAJI, R.V., KUMAR, N.S., PULIMOOD, A., and PATRA, S. (2003). Amelioration of dextran sulfate colitis by butyrate: Role of heat shock protein 70 and NF-kappaB. Am. J. Physiol. 285, G177-G184.
39. VREUGDENHIL, A.C., DENTENER, M.A., SNOEK, A.M., GREVE, J.W., and BUURMAN, W.A. (1999). Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J. Immunol. 163, 2792-2798.
40. WU, G.D., HUANG, N., WEN, X., KEILBAUGH, S.A., and YANG, H. (1999). High-level expression of I kappa B-beta in the surface epithelium of the colon: In vitro evidence for an immunomodulatory role. J. Leukoc. Biol. 66, 1049-1056.
41. YIN, L., LAEVSKY, G., and GIARDINA, C. (2001). Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J. Biol. Chem. 276, 44641-44646.
42. YU, S.J., BOUDREAU, F., DESILETS, A., HOUDE, M., RIVARD, N., and ASSELIN, C. (1999). Attenuation of haptoglobin gene expression by TGFbeta requires the MAP kinase pathway. Biochem. Biophys. Res. Commun. 259, 544-549.